Atsuko Sato

Atsuko Sato

Auto-generated profile, based on publicly available information

Atsuko Sato

Cell Signal Unit, Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in Cancer Gene Therapy
Verified
Journal Article
Open access
PDF file
MTMiho Tokumasu
Miho Tokumasu
ASAtsuko Sato
Atsuko Sato
TITaku Ito-Kureha
Taku Ito-Kureha
MYMizuki Yamamoto
Mizuki Yamamoto
NONao Ohmine
Nao Ohmine
TYTadashi Yamamoto
Tadashi Yamamoto
NF-κB mediates transcriptional regulation crucial to many biological functions, and elevated NF-κB activity leads to autoimmune and inflammatory diseases, as well as cancer. Since highly aggressive breast cancers have few therapeutic molecular targets, clarification of key molecular mechanisms of NF-κB signaling would facilitate the development of more effective therapy. In this report, we show that Tob, a member of the Tob/BTG family of antiproliferative proteins, acts as a negative regulator of the NF-κB signal in breast cancer. Studies with 35 human breast cancer cell lines reveal that Tob expression is negatively correlated with NF-κB activity. Analysis of The Cancer Genome Atlas (TCGA) database of clinical samples reveals an inverse correlation between Tob expression and NF-κB activity. Tob knockdown in human breast cancer cells promoted overactivation of NF-κB upon TNF-α treatment, whereas overexpression of Tob inhibited TNF-α stimulation-dependent NF-κB activation. Mechanistically, Tob associates with the TNF receptor complex I and consequently inhibits RIPK1 polyubiquitylation, leading to possible prevention of overwhelming activation of NF-κB.

20 October 2021 in The Japanese Journal of Urology
Verified
Journal Article
Open access
PDF file
YMYosuke Morizawa
Yosuke Morizawa
HSHiroyuki Satoh
Hiroyuki Satoh
ASAtsuko Sato
Atsuko Sato
SIShun Iwasa
Shun Iwasa
YAYujiro Aoki
Yujiro Aoki
(背景) 脊髄係留症候群とは脊髄下端が尾側組織に係留し,さまざまな神経障害をきたすことをいう.中でも排尿障害は早期に出現することが多い.昼間尿失禁を主訴に泌尿器科を受診し,脊髄係留症候群の診断に至った小児症例について検討した. (対象と方法) 2011年3月から2017年10月に昼間尿失禁を主訴に泌尿器科を受診し,脊髄係留症候群と診断された18例.脊髄係留症候群の診断契機,係留解除術前後の臨床症状の変化について検討した. (結果) 男児9例,女児9例.初診時の平均年齢は6.3歳(範囲4~9歳).難治性の昼間尿失禁として全例にウロダイナミクスおよびVCUGを施行した.全例に脊仙MRIを施行し,その理由はVCUGおよびウロナミクスでの異常所見の精査であった.終糸脂肪腫8例,潜在性脊髄係留症候群4例,低位脊髄円錐4例,円錐部脂肪腫1例,仙骨内髄膜囊胞1例でMRIでの解剖学的脊髄係留所見を認めたのは4例のみであった.脊髄係留解除術後の平均観察期間は66.3カ月(22~116カ月)で,11例で無症状,4例は夜尿症のみが残存,3例は間欠導尿での管理となっている. (結語) 昼間尿失禁が脊髄係留症候群の症状の一つとなっている症例が存在することを想定し,診療を行う必要がある.ウロダイナミクスでの膀胱機能評価が,脊髄係留症候群の診断契機となりうる.